Surgery for Mesothelioma

Surgical Treatments for Pleural Mesothelioma

There are a variety of surgical procedures and treatments for pleural mesothelioma. Below is an overview of a few of the most frequent ones used in patients.

Pleurocentesis

This procedure is used to minimize pleural effusion, the build-up of fluid in the pleural space surrounding the lungs. The fluid can make it difficult for a mesothelioma patient to breath. The procedure involves the surgical puncture and drainage of the thoracic cavity and is usually performed in an outpatient setting with a long, thin needle that is inserted into the pleural space.

Pleurodesis

Pleurodesis is a surgical procedure that uses chemicals, talc or drugs to scar the space between the layers of the pleura. First, fluid is drained from the space using a catheter or chest tube. Next, the chemical, talc or drug is put into the space. The scarring stops the build-up of fluid in the pleural cavity. This is sometimes referred to as a “talc procedure.”

Pleurectomy / Decortication

Pleurectomy / Decortication refers to a lung-sparring surgery to remove the mesothelioma cancer by removing part of the covering of the lungs, lining of the chest, and part of the outside surface of the lungs. The goals of the operation are to re-expand the lung and remove the disease process affecting the pleural space so that pulmonary (lung) function and symptoms will improve.

Pneumonectomy

A pneumonectomy is a surgery that involves the removal of the lung that has been affected by mesothelioma. It has become the standard surgery for operable locally advanced lung cancer.

Extrapleural Pneumonectomy

An Extrapleural Pneumonectomy or EPP is the most invasive surgery for mesothelioma and involves the removal of the diseased lung, part of the pericardium, (the membrane that covers the heart), part of the diaphragm (the muscle that lies between the abdomen and the lungs), and part of the parietal pleura (this is the membrane that lines the chest). An EPP is typically performed only on patients with early stage localized disease that has not metastasized to the lymph nodes or to other tissues and organs. Sometimes heated chemotherapy is introduced during an EPP in order to bathe affected tissues. Although an EPP can impact life expectancy for some patients, there can be significant risks to this procedure. These risks may include: internal bleeding, respiratory failure, infection and blood clots. In addition, some patients undergoing extrapleural pneumonectomy die during or immediately following the procedure. That percentage is, however, lower at medical centers that specialize in this surgery.

Controversy

Perhaps the greatest area of dispute now is whether an extrapleural pneumonectomy (EPP) or pleurectomy / decortication is the most appropriate curative operation for mesothelioma patients who are candidates for both procedures. There are leading mesothelioma surgeons who take contrary point of view. For example, Dr. Robert Cameron at UCLA has endorsed a lung sparring approach while Dr. David Sugarbaker of Brigham and Women’s Hospital has advocated for EPP. The 2011 MARS study (Mesothelioma and Radical Surgery randomized feasibility study) concluded that, “radical surgery in the form of EPP within trimodal therapy offers no benefit and possibly harms patients.”

Surgical Treatments for Peritoneal Mesothelioma

Paracentesis

Similar to pleurocentesis, paracentesis is a procedure in which fluid from the abdomen is removed through a needle. It is performed on peritoneal mesothelioma patients to remove pressure from the fluid.

Peritonectomy / Cytoreductive Surgery

Peritonectomy is the most common surgical procedure for peritoneal mesothelioma and involves the removal or stripping of the affected peritoneum (cancerous part of the lining of the abdominal cavity) from the underlying tissue. Peritonectomy is usually combined with cytoreductive surgery where the goal is to also remove as much of the cancerous growth as possible from multiple sites in the abdomen. The greater omentum is nearly always involved and has to be removed.

HIPEC

Doctors often perform cytoreductive surgery in combination with other mesothelioma treatments such a chemotherapy. For example, in a HIPEC procedure (heated intraperitoneal chemotherapy), surgeons introduce heated chemotherapy directly into the surgical cavity. In the peer reviewed medical literature, HIPEC procedures used in peritoneal mesothelioma management report superior survival statistics when compared to other surgeries.

Related Posts

Extending Mesothelioma Survival with Chemotherapy - In the continued quest to improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma, two new studies have been published this week on the effectiveness of adding additional drugs to the standard combination. The majority of patients who receive a mesothelioma diagnosis will have treatment that includes chemotherapy. According to data from the National Cancer Institute’s SEER database, the chemotherapy regimen prescribed most often … Continue reading Extending Mesothelioma Survival with Chemotherapy »

Mesothelioma Outcomes Better at High Volume Facilities - A new study provides more evidence that malignant pleural mesothelioma patients considering surgery would do well to seek out a facility that does a lot of them. Researchers found that mesothelioma patients tend to have fewer complications and shorter hospital stays when they are treated at high volume facilities. The new study is based on data from the National Cancer Database and is published in … Continue reading Mesothelioma Outcomes Better at High Volume Facilities »

Minimally-Invasive CRS/HIPEC: Could it Revolutionize Mesothelioma Surgery? - A new study out of Spain suggests that it might be possible to perform the surgery that has become the standard of care for peritoneal mesothelioma in a much less invasive way. Cytoreductive surgery with heated intraperitoneal chemotherapy (CRS/HIPEC) has dramatically changed the survival odds for people with the abdominal form of malignant mesothelioma, also known as asbestos cancer. Now, researchers at the University Hospital … Continue reading Minimally-Invasive CRS/HIPEC: Could it Revolutionize Mesothelioma Surgery? »

Plasma-Based Surgery May Be Safer Alternative for Some Mesothelioma Patients - A minimally-invasive surgical technique that uses plasma energy to destroy diseased pleural tissue may be a safer alternative for mesothelioma patients who would not otherwise be candidates for surgery. Doctors at Harefield Hospital in the UK are reporting good results and no serious side effects from using the PlasmaJet Surgical System to operate on a patient with malignant pleural mesothelioma. PlasmaJet uses the energy of … Continue reading Plasma-Based Surgery May Be Safer Alternative for Some Mesothelioma Patients »

Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival - A new study from the University of Illinois suggests that patients with peritoneal mesothelioma who undergo  surgery may not get any benefit from having chemotherapy, too. Mesothelioma patients who have cytoreductive surgery, which is also called debulking surgery, tend to live more than four times as long as those who do not have the surgery. Rinsing the abdominal cavity with a heated solution of cancer-killing … Continue reading Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival »

New Surgical Technique May Improve Mesothelioma Survival - A new study is asking the question, is it possible to remove a malignant mesothelioma tumor with pleurectomy-decortication (P/D) without risking the spread of new tumors? P/D, the lung-sparing pleural mesothelioma surgery, has become the preferred approach in many cases where mesothelioma has not spread to the lung tissue. Most studies have found that P/D has a lower complication rate, produces less pain, and allows for faster … Continue reading New Surgical Technique May Improve Mesothelioma Survival »

Pleural Mesothelioma Treatment Disparities Seen in Lung Cancer Patients, Too - A new study on treatment disparities among lung cancer patients reflects a trend that has been documented among mesothelioma patients, as well; patients who are black or economically disadvantaged are less likely to get potentially life-saving treatments. Like non-small cell lung cancer, pleural mesothelioma affects the lungs. The standard of care is for patients to have a combination of chemotherapy and radiotherapy. For malignant mesothelioma … Continue reading Pleural Mesothelioma Treatment Disparities Seen in Lung Cancer Patients, Too »

Mesothelioma Survival After Talc Pleurodesis - Pleural mesothelioma patients considering pleurodesis for excess lung fluid should know that there is very little data on how this procedure may affect survival or even quality of life. That is the conclusion of researchers at Mount Sinai Medical School in New York. Scientists with the Institute for Translational Epidemiology combed the medical literature for studies demonstrating mesothelioma survival after talc pleurodesis for lung fluid … Continue reading Mesothelioma Survival After Talc Pleurodesis »

Predicting Mesothelioma Survival: A New Model - Could a geometric diagram hold the key to predicting the treatment outcomes of patients with malignant pleural mesothelioma? A team of thoracic surgery experts at China’s Fudan University believe the answer is yes. The team has developed such a diagram, called a nomogram, and used it to demonstrate the connection between a list of prognostic factors and actual mesothelioma survival. Predicting Mesothelioma Prognosis The new … Continue reading Predicting Mesothelioma Survival: A New Model »

CRS/HIPEC May Extend Survival in Rare Form of Peritoneal Mesothelioma - There has been an exciting new development in the treatment of one of the most aggressive forms of peritoneal mesothelioma. Biphasic mesothelioma is a variant of malignant mesothelioma that is even less responsive to standard cancer treatments than the more common epithelioid subtype. Many studies of peritoneal mesothelioma treatment have focused on people with the epithelioid form of the asbestos cancer, but much less is … Continue reading CRS/HIPEC May Extend Survival in Rare Form of Peritoneal Mesothelioma »